RxDoctor Payments DataLook up a doctor →

Michael McMains, MD

Orthopaedic Surgery of the Spine · Indianapolis, INNPI 1831485358

Payments from drug & device makers

$951,246in general payments, 2019–2025

Across 487 payments — averaging $1953.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$633K
  • Medtronic$270K
  • Arthrex$14K
  • Kuros Biosciences USA, Inc$8K
  • Medical Device Business Services, Inc.$6K
  • Depuy Synthes Products, Inc.$5K
  • plus $15K from 25 others

What the payments were for

  • Royalty or licence$77,41411%
  • Consulting fees$438,78264%
  • Speaking & faculty fees$16,0002%
  • Travel & lodging$139,26420%
  • Food & beverage$14,3202%
  • Gifts$340%
  • Entertainment$1380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$951,246 in reported general payments places this provider in the 85th percentile of 48 orthopaedic surgery of the spine providers in Indiana.

See all orthopaedic surgery of the spine providers in Indiana

Medicare billing

Part B allowed, 2024
$167,142
Medicare patients
242
Services billed
1,059

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl31$520
Celecoxib13$222
Gabapentin21$123

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →